Vanti, G.; Coronnello, M.; Bani, D.; Mannini, A.; Bergonzi, M.C.; Bilia, A.R.
Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression. Pharmaceutics 2021, 13, 306.
https://doi.org/10.3390/pharmaceutics13030306
AMA Style
Vanti G, Coronnello M, Bani D, Mannini A, Bergonzi MC, Bilia AR.
Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression. Pharmaceutics. 2021; 13(3):306.
https://doi.org/10.3390/pharmaceutics13030306
Chicago/Turabian Style
Vanti, Giulia, Marcella Coronnello, Daniele Bani, Antonella Mannini, Maria Camilla Bergonzi, and Anna Rita Bilia.
2021. "Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression" Pharmaceutics 13, no. 3: 306.
https://doi.org/10.3390/pharmaceutics13030306
APA Style
Vanti, G., Coronnello, M., Bani, D., Mannini, A., Bergonzi, M. C., & Bilia, A. R.
(2021). Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression. Pharmaceutics, 13(3), 306.
https://doi.org/10.3390/pharmaceutics13030306